Written by Klarity Editorial Team
Published: May 19, 2026

You can get a tirzepatide online prescription through a licensed telehealth provider — and for many people, it may be the most effective weight loss medication available today. Tirzepatide (brand names Mounjaro and Zepbound) is a once-weekly injectable medication that activates two hormone pathways simultaneously, producing greater weight loss than any previously approved medication in clinical trials. Platforms like Klarity Health connect patients with 2,000+ licensed providers who can evaluate your eligibility and prescribe tirzepatide from the comfort of your home.
This guide covers what tirzepatide is, who qualifies, how the online prescription process works, and what to expect at your telehealth appointment.
Tirzepatide is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. While traditional GLP-1 medications like semaglutide activate only the GLP-1 hormone pathway, tirzepatide simultaneously activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors.
This dual-action mechanism produces more powerful metabolic effects:
The results in clinical trials are remarkable. In the SURMOUNT-1 trial, participants on the highest dose of tirzepatide (15 mg/week) lost an average of 22.5% of their body weight over 72 weeks — roughly double the weight loss seen with lifestyle changes alone and meaningfully greater than semaglutide trials.
Mounjaro vs. Zepbound: Both contain tirzepatide. Mounjaro is FDA-approved for type 2 diabetes management. Zepbound received FDA approval in November 2023 specifically for chronic weight management in adults with obesity or overweight with at least one related health condition. A provider may prescribe either depending on your diagnosis, insurance, and availability.
Because tirzepatide is a prescription medication, a licensed provider must evaluate your medical history and determine whether it is appropriate for you. The general qualification criteria align with FDA-approved labeling.
You may qualify for tirzepatide if you:
Situations that may affect eligibility:
Your Klarity provider will review your complete medical history during your consultation. If tirzepatide is not appropriate for you, they may recommend an alternative such as semaglutide (Ozempic/Wegovy).
Klarity Health has streamlined the telehealth process so you can go from intake form to prescription in as little as one business day. Here's the step-by-step:
Step 1: Complete the online health intake
Go to helloklarity.com and fill out a brief medical questionnaire. You'll provide information about your weight, height, health history, current medications, and weight loss goals. This is reviewed before your appointment, so your provider arrives prepared.
Step 2: Get matched with a licensed provider
Klarity's network includes 2,000+ licensed physicians, nurse practitioners, and physician assistants across the U.S., many of whom specialize in metabolic health and weight management. You'll be matched with a provider licensed in your state.
Step 3: Attend your telehealth appointment
Your appointment takes place via secure video call — typically 20–30 minutes for a first visit. Your provider will discuss your health history, evaluate your eligibility for tirzepatide, explain what the medication does, walk through expected results and side effects, and answer your questions.
Step 4: Receive your prescription
If tirzepatide is prescribed, your provider sends the prescription electronically to your preferred pharmacy. Many patients opt for mail-order pharmacies for home delivery. Your provider will specify the starting dose and titration schedule.
Step 5: Follow-up care and dose adjustments
Tirzepatide is started at 2.5 mg/week for four weeks, then increased in 2.5 mg increments every four weeks up to 15 mg/week based on tolerability and response. Your Klarity provider will monitor your progress at follow-up appointments and guide your dose escalation.
To learn more about GLP-1 and dual-agonist medications available through Klarity, visit the GLP-1 weight loss prescriptions page.
First appointments for weight loss medication follow a structured clinical evaluation. Here is what yours will typically include:
History of weight and prior treatments: Your provider will ask about your weight history, what lifestyle interventions you've tried, and any prior use of weight loss medications or bariatric procedures. This context helps them understand your metabolic profile.
Contraindication screening: Your provider will specifically ask about thyroid cancer history (personal and family), as tirzepatide carries an FDA black-box warning related to MTC risk observed in rodent studies. They will also screen for pancreatitis history, current medications, and kidney function.
Medication comparison: If you've been considering both semaglutide and tirzepatide, your provider can walk you through the differences — including efficacy data, cost, insurance coverage differences, and injection frequency (both are once weekly). They will help you decide which medication makes the most sense for your situation.
Injection education: Both Mounjaro and Zepbound come in pre-filled auto-injector pens. Your provider will explain how to self-administer the injection (typically in the abdomen, thigh, or upper arm), how to store the medication, and what to do if you miss a dose.
Side effect management: Gastrointestinal side effects — primarily nausea, diarrhea, vomiting, and constipation — are the most common complaints during the dose titration period. Your provider will give you practical tips to manage these: eating smaller, lower-fat meals; eating slowly; avoiding lying down after meals; and staying well hydrated.
Q: Is tirzepatide the same as Ozempic?
A: No. Both are injectable weight loss medications, but they have different mechanisms. Ozempic contains semaglutide, a GLP-1 receptor agonist. Tirzepatide (Mounjaro/Zepbound) is a dual GIP/GLP-1 receptor agonist. Clinical data generally shows tirzepatide produces greater weight loss than semaglutide, though both are effective options.
Q: How much does tirzepatide cost without insurance?
A: Without insurance, Mounjaro and Zepbound typically cost between $900 and $1,200 per month. Eli Lilly offers a savings program that can reduce out-of-pocket costs for eligible patients. Your Klarity provider can discuss cost-saving strategies, including whether compounded tirzepatide might be an option in your situation.
Q: How fast does tirzepatide work for weight loss?
A: Many patients notice reduced appetite within the first week of starting tirzepatide. Meaningful weight loss (3–5% of body weight) is typically visible by weeks 8–12. The greatest weight loss occurs as doses are increased over the first six months of treatment.
Q: Can I switch from semaglutide (Ozempic/Wegovy) to tirzepatide?
A: In many cases, yes. Your Klarity provider can evaluate whether switching medications makes sense based on your response to semaglutide, any side effects you experienced, and your current health status. Switching requires a washout period to avoid overlapping GLP-1 activity.
Q: Does tirzepatide require any lab work before starting?
A: Your provider will determine whether lab work is needed based on your intake information. Common baseline tests may include a metabolic panel, thyroid function tests, HbA1c, and a lipid panel — particularly if you have diabetes or other metabolic conditions.
Tirzepatide represents a meaningful advance in medical weight management, and you can access it through a licensed telehealth provider without ever leaving your home. Klarity's network of 2,000+ licensed providers is available to evaluate your eligibility, answer your questions, and support you through your treatment journey.
Ready to get started? See if you qualify at helloklarity.com.
Last medically reviewed: May 2026
Find the right provider for your needs — select your state to find expert care near you.